BCG Vaccination to Protect Healthcare Workers Against COVID-19
Status:
Active, not recruiting
Trial end date:
2022-03-30
Target enrollment:
Participant gender:
Summary
Phase III, two-group multicentre, randomised controlled trial in up to 10 078 healthcare
workers to determine if BCG vaccination reduces the incidence and severity of COVID-19 during
the 2020 pandemic.
Phase:
Phase 3
Details
Lead Sponsor:
Murdoch Childrens Research Institute
Collaborators:
Bill and Melinda Gates Foundation Royal Children's Hospital